Report: Clinical trial opinions in rare disease

Results from our 2020 survey reveal drivers and barriers to clinical trial participation

As it became clear that 2020 would be a year like no other, we surveyed members of our rare disease community to learn more about their attitudes and opinions around clinical trials. We wanted to find out how willing people were to take part in trials, what they felt about decentralized trial designs and whether COVID-19 had an impact on their opinions.

Get in touch

Interested in hearing more? Feel free to reach out to us, and we’ll make sure to get back to you as soon as possible.